Background Insomnia is the most reported sleep disorder in industrialized countries, affecting, in the chronic form, around 10% of the European population. In Italy, such a percentage seems to be even higher. Although insomnia can be an independent disorder, it is frequently described as comorbid condition and may precipitate, exacerbate, or...
-
2023 (v1)PublicationUploaded on: January 31, 2024
-
2022 (v1)Publication
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt alpha-synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from diagnosis. Several markers of phenoconversion were identified; however, most studies investigated biomarkers separately, with retrospective study designs, in small...
Uploaded on: February 13, 2024 -
2023 (v1)Publication
No description
Uploaded on: February 13, 2024 -
2022 (v1)Publication
Introduction Narcolepsy is a chronic and rare hypersomnia of central origin characterized by excessive daytime sleepiness and a complex array of symptoms as well as by several medical comorbidities. With growing pharmacological options, polytherapy may increase the possibility of a patient-centered management of narcolepsy symptoms. The aims of...
Uploaded on: December 16, 2023 -
2019 (v1)Publication
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. This provides an unprecedented opportunity to directly observe prodromal neurodegenerative states, and potentially intervene with neuroprotective therapy. For future neuroprotective trials, it...
Uploaded on: March 27, 2023